Monday, September 29, 2008
For further information, contact
Judy Naus at 651-286-8623
Biotel Announces Record Revenues and Earnings for Fiscal 2008
Minneapolis, September 29, 2008 — Biotel Inc. (Bulletin Board: BTEL.OB) announced results for the year ended June 30, 2008,
with net earnings of $666,000, or $0.23 per diluted share, on revenues of $11,495,000. This compares to net earnings of $520,000,
or $0.19 per share, on revenues of $11,233,000 for the prior year. For its fourth quarter, the company reported net earnings of
$191,000, or $0.07 per diluted share, on revenues of $3,187,000. This compares to net earnings of $221,000, or $0.08 per diluted
share, on revenues of $3,115,000 in the fourth quarter of 2007.
Highlights for the quarter and year are as follows:
“Biotel achieved a record fiscal year in revenues and earnings with a strong improvement in the fourth quarter over the third
quarter,” Biotel President and CEO Steve Springrose said. “Our Braemar Holter devices, event recorders, liposuction and other
medical devices made strong revenue contributions, and our Agility 24/7 cardiac monitoring services continued to make very
strong year over year gains. The highlight of the quarter was the introduction of our new ER920W cardiac arrhythmia monitor,
our first entry into the high potential wireless market. Very importantly, we have already received FDA 510(k) approval of our
next generation wireless monitor employing ‘Fusion’ technology, scheduled for product introduction in early calendar 2009.
Biotel serves as a development partner to medical corporations seeking new devices and clinical research services.”
• Sixth year in a row of profitable growth.
• Record sales for the fourth quarter and year
• Net income for the year up 28.1 percent over 2007
• Gross margin for the year was 44.4% versus 42.6% last year